Intracranial Langerhans cell Histiocytosis: A review

Introduction: Intracranial Langerhans Cell Histiocytosis (LCH) is a rare disease caused by the proliferation and dissemination of antigen presenting cells in the skin. Few cases have been reported on to date and there is a lack of consensus on the most effective means of diagnosis and treatment of t...

Full description

Bibliographic Details
Main Authors: Zachary C. Gersey, MD, MS, Ian Zheng, MD, Amade Bregy, MD, PhD, Nitin Agarwal, MD, Ricardo J. Komotar, MD
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Interdisciplinary Neurosurgery
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S221475192030092X
_version_ 1819151752098742272
author Zachary C. Gersey, MD, MS
Ian Zheng, MD
Amade Bregy, MD, PhD
Nitin Agarwal, MD
Ricardo J. Komotar, MD
author_facet Zachary C. Gersey, MD, MS
Ian Zheng, MD
Amade Bregy, MD, PhD
Nitin Agarwal, MD
Ricardo J. Komotar, MD
author_sort Zachary C. Gersey, MD, MS
collection DOAJ
description Introduction: Intracranial Langerhans Cell Histiocytosis (LCH) is a rare disease caused by the proliferation and dissemination of antigen presenting cells in the skin. Few cases have been reported on to date and there is a lack of consensus on the most effective means of diagnosis and treatment of these lesions. This paper will serve as a review of this malady. Methods: MeSH database search was performed to include all relevant studies on intracranial LCH. Results: A total of 146 studies with 192 patients were included in our review. Men were more commonly affected and the average age of diagnosis was 31.6 and 28.0 in men and women respectively. CT and MRI were the most common imaging modalities. The majority of the case reports performed biopsies and the most common lesion location was the hypothalamus-pituitary axis. All studies used surgical resection, radiotherapy, chemotherapy or combination therapy as means of treatment, with resection plus chemotherapy being the most successful. 74 cases were successful in preventing recurrence. Conclusion: LCH rarely affects the brain as primary or secondary focus. Biopsy is required for precise diagnosis and exclusion of other intracranial lesions. There is no standard treatment for LCH of the central nervous system, but this review may serve as a guide to chronicle previous efficacious therapeutics strategies.
first_indexed 2024-12-22T14:38:23Z
format Article
id doaj.art-86092e3ef63b4e2eab27fc4858c7bfd6
institution Directory Open Access Journal
issn 2214-7519
language English
last_indexed 2024-12-22T14:38:23Z
publishDate 2020-09-01
publisher Elsevier
record_format Article
series Interdisciplinary Neurosurgery
spelling doaj.art-86092e3ef63b4e2eab27fc4858c7bfd62022-12-21T18:22:37ZengElsevierInterdisciplinary Neurosurgery2214-75192020-09-0121100729Intracranial Langerhans cell Histiocytosis: A reviewZachary C. Gersey, MD, MS0Ian Zheng, MD1Amade Bregy, MD, PhD2Nitin Agarwal, MD3Ricardo J. Komotar, MD4Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, United StatesDepartment of Neurological Surgery, University of Miami Miller School of Medicine Miami, FL, United StatesDepartment of Neurological Surgery, University of Miami Miller School of Medicine Miami, FL, United StatesDepartment of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, United StatesDepartment of Neurological Surgery, University of Miami Miller School of Medicine Miami, FL, United States; Corresponding author at: Department of Neurological Surgery, University of Miami School of Medicine, Director of Surgical Neurooncology, University of Miami Hospital, Co-Director of Surgical Neurooncology, Sylvester Comprehensive Cancer Center, Co-Director of Surgical Neurooncology, University of Miami Health Clinics, University of Miami Hospital, West Building, Suite 306, Miami, FL, 33125, United States.Introduction: Intracranial Langerhans Cell Histiocytosis (LCH) is a rare disease caused by the proliferation and dissemination of antigen presenting cells in the skin. Few cases have been reported on to date and there is a lack of consensus on the most effective means of diagnosis and treatment of these lesions. This paper will serve as a review of this malady. Methods: MeSH database search was performed to include all relevant studies on intracranial LCH. Results: A total of 146 studies with 192 patients were included in our review. Men were more commonly affected and the average age of diagnosis was 31.6 and 28.0 in men and women respectively. CT and MRI were the most common imaging modalities. The majority of the case reports performed biopsies and the most common lesion location was the hypothalamus-pituitary axis. All studies used surgical resection, radiotherapy, chemotherapy or combination therapy as means of treatment, with resection plus chemotherapy being the most successful. 74 cases were successful in preventing recurrence. Conclusion: LCH rarely affects the brain as primary or secondary focus. Biopsy is required for precise diagnosis and exclusion of other intracranial lesions. There is no standard treatment for LCH of the central nervous system, but this review may serve as a guide to chronicle previous efficacious therapeutics strategies.http://www.sciencedirect.com/science/article/pii/S221475192030092XIntracranialDiabetes InsipidusLangerhans Cell HistiocytosisHumanRare Diseases
spellingShingle Zachary C. Gersey, MD, MS
Ian Zheng, MD
Amade Bregy, MD, PhD
Nitin Agarwal, MD
Ricardo J. Komotar, MD
Intracranial Langerhans cell Histiocytosis: A review
Interdisciplinary Neurosurgery
Intracranial
Diabetes Insipidus
Langerhans Cell Histiocytosis
Human
Rare Diseases
title Intracranial Langerhans cell Histiocytosis: A review
title_full Intracranial Langerhans cell Histiocytosis: A review
title_fullStr Intracranial Langerhans cell Histiocytosis: A review
title_full_unstemmed Intracranial Langerhans cell Histiocytosis: A review
title_short Intracranial Langerhans cell Histiocytosis: A review
title_sort intracranial langerhans cell histiocytosis a review
topic Intracranial
Diabetes Insipidus
Langerhans Cell Histiocytosis
Human
Rare Diseases
url http://www.sciencedirect.com/science/article/pii/S221475192030092X
work_keys_str_mv AT zacharycgerseymdms intracraniallangerhanscellhistiocytosisareview
AT ianzhengmd intracraniallangerhanscellhistiocytosisareview
AT amadebregymdphd intracraniallangerhanscellhistiocytosisareview
AT nitinagarwalmd intracraniallangerhanscellhistiocytosisareview
AT ricardojkomotarmd intracraniallangerhanscellhistiocytosisareview